Glenmark Pharmaceuticals Limited has informed the Exchange about Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015
GLENMARK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Glenmark Pharmaceuticals has submitted a disclosure to the stock exchange as required under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. Regulation 30 filings are used by listed companies to share material events or updates that may affect investors' decisions. The specific details of the disclosure are not mentioned in the headline itself. Investors should refer to the full filing on the NSE/BSE website or the company's investor relations page for complete information.
The actual impact on shareholders depends on the content of the underlying disclosure, which is not specified in the headline. Investors are advised to check the full filing to understand any material developments.